Moreover, the status of SMAD4 influences the normal function of the TGF-β signaling pathway, whose aberrant activation contributes to the shaping of the tumor microenvironment, promoting tumor cell invasion, migration, and neovascularization, ultimately leading to the deterioration and poor prognosis of CRC.15 The gene discussed is TGFB1; the disease is neoplasm.